Minimising the consequences of narcolepsy

Drugs and Therapy Perspectives

Volumn 8, Issue 11, 1996, Pages 7-10

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

CLOMIPRAMINE; CLONIDINE; DEXAMPHETAMINE; FEMOXETINE; FENCAMFAMIN; FLUOXETINE; HYDROXYBUTYRIC ACID; MAZINDOL; METHYLPHENIDATE; MODAFINIL; PEMOLINE; PROLINTANE; PROTRIPTYLINE; SELEGILINE; VILOXAZINE;

CATAPLEXY; DRUG TOLERANCE; HUMAN; NARCOLEPSY; SHORT SURVEY; SOMNOLENCE;

EID: 0029829830     PISSN: 11720360     EISSN: None     Source Type: Journal    
DOI: 10.2165/00042310-199608110-00003     Document Type: Short Survey

References (10)

1. Narcolepsy. In: Isselbacher KJ, et al., editors. Harrison's principles of internal medicine, 13th ed. New York: McGraw-Hill, 1994: 167-8
2. Aldrich MS. The clinical spectrum of narcolepsy and idiopathic hypersomnia. Neurology 1996 Feb: 46: 393-401
3. Aldrich MS. Narcolepsy. N Engl J Med 1990 Aug 9; 323: 389-94
4. Hublin C. Narcolepsy: current drug treatment options. CNS Drugs 1996 Jun; 5 (6); 426-36
5. British National Formulary No. 31. London: The Pharmaceutical Press, 1996 Mar: 170-9
6. Martindale. The Extra Pharmacopoeia, 30th ed. London: Pharmaceutical Press, 1993
7. Dictionnarie Vidal 1996. 72nd ed. Paris: OVP Editions du Vidal, 1996: 1016-7
8. Scharf MB, Brown D, Woods M, et al. The effects and effectiveness of γ-hydroxybutyrate in patients with narcolepsy. J Clin Psychiatry 1985 Jun; 46 (6): 222-5
9. T Milter MM, Aldrich MS, Koob GF, et al. Narcolepsy and its treatment with stimulants (ASDA standards of practice). Sleep 1994; 17: 352-71
10. Chen SY, Clift SJ, Dahlitz MJ et al. Treatment in the narcoleptic syndrome: self assessment of the action of dexamphetamine and clomipramine. J Sleep Res 1995; 4: 113-8